IFN increases class I MHC antigen expression on adenovirus-infected human cells without inducing resistance to natural killer cell killing
- PMID: 1382100
IFN increases class I MHC antigen expression on adenovirus-infected human cells without inducing resistance to natural killer cell killing
Abstract
It has been previously shown that unstimulated NK cells cannot preferentially lyse adenovirus serotypes 2 and 5-infected human cells. In this study, the ability of IFN to promote the selective NK cell-mediated lysis of adenovirus-infected human cells was determined. The relationship between target cell susceptibility to NK cell-mediated killing and class I Ag expression was also analyzed through the use of adenovirus serotype 2 and 5 mutants that do not make the adenovirus early region 3 19-kDa class I binding protein. IFN induced the selective lysis of adenovirus serotype 2 and 5-infected human cells by activating NK cells (IFN-alpha) and protecting uninfected, but not adenovirus-infected cells, from NK cell-mediated lysis (IFN-gamma). IFN-gamma increased the expression of class I Ag on the surface of cells infected with the adenovirus early region 3 deletion mutants, dl327 or dl801, to a level equal to or greater than that expressed on uninfected cells. Despite the increased expression of class I Ag, IFN-gamma could not protect these adenovirus-infected cells from NK cell-mediated lysis. Thus, dl327 or dl801 infection prevented IFN-gamma's induction of cytolytic resistance to NK cell-mediated killing but left IFN-gamma's induction of class I Ag intact. Surface class I Ag levels were substantially higher on IFN-gamma-treated, dl327-, and dl801-infected cells in comparison to cells infected with wild type adenovirus serotype 5. Again, higher target cell levels of class I Ag did not correlate with increased resistance to NK cell-mediated lysis because there was equivalent NK cell-mediated killing of IFN-gamma-treated adenovirus serotype 5-, dl327-, or dl801-infected cells. Thus, IFN-gamma only protects uninfected cells from NK cell-mediated killing, irrespective of target class I Ag levels, and thereby concentrates NK lytic activity on just adenovirus-infected cells. These data demonstrate that IFN-gamma's ability to protect target cells from NK cell-mediated cytolysis is unrelated to IFN-gamma's induction of surface class I MHC Ag.
Similar articles
-
Cytokines alter target cell susceptibility to lysis: I. Evaluation of non-major histocompatibility complex-restricted effectors reveals differential effects on natural and lymphokine-activated killing.J Biol Response Mod. 1990 Apr;9(2):113-26. J Biol Response Mod. 1990. PMID: 2111373
-
Adenovirus E1A inhibits IFN-induced resistance to cytolysis by natural killer cells.J Immunol. 1993 May 15;150(10):4315-22. J Immunol. 1993. PMID: 7683316
-
Dual effects of cytokines in regulation of MHC-unrestricted cell mediated cytotoxicity.Crit Rev Immunol. 1993;13(1):1-34. Crit Rev Immunol. 1993. PMID: 8466640 Review.
-
Inability of interferon to protect virus-infected cells against lysis by natural killer (NK) cells correlates with NK cell-mediated antiviral effects in vivo.J Immunol. 1985 Nov;135(5):3537-41. J Immunol. 1985. PMID: 2413125
-
Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts).Clin Ter. 2006 Jul-Aug;157(4):377-86. Clin Ter. 2006. Retraction in: Clin Ter. 2008 May-Jun;159(3):207. PMID: 17051976 Retracted. Review.
Cited by
-
Human adenovirus-specific CD8+ T-cell responses are not inhibited by E3-19K in the presence of gamma interferon.J Virol. 1996 Sep;70(9):6314-22. doi: 10.1128/JVI.70.9.6314-6322.1996. J Virol. 1996. PMID: 8709259 Free PMC article.
-
Protection against natural killer cells by interferon-gamma treatment of K562 cells cannot be explained by augmented major histocompatibility complex class I expression.Immunology. 1994 Sep;83(1):75-80. Immunology. 1994. PMID: 7821970 Free PMC article.
-
Aristocratic human papillomavirus drove cervical cancer: a study of the therapeutic potential of the combination of interferon with zinc.Mol Cell Biochem. 2021 Feb;476(2):757-765. doi: 10.1007/s11010-020-03941-1. Epub 2020 Oct 24. Mol Cell Biochem. 2021. PMID: 33099745 Review.
-
What is the role of alternate splicing in antigen presentation by major histocompatibility complex class I molecules?Immunol Res. 2010 Mar;46(1-3):32-44. doi: 10.1007/s12026-009-8123-8. Immunol Res. 2010. PMID: 19830395 Free PMC article. Review.
-
Bispecific Antibodies for Multiple Myeloma: A Review of Targets, Drugs, Clinical Trials, and Future Directions.Front Immunol. 2020 Apr 24;11:501. doi: 10.3389/fimmu.2020.00501. eCollection 2020. Front Immunol. 2020. PMID: 32391000 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Research Materials